Weijie Ouyang

Weijie Ouyang

Auto-generated profile, based on publicly available information

Weijie Ouyang

Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guizhou Medical University, Guizhou, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
SWShoubi Wang
Shoubi Wang
XWXiaoran Wang
Xiaoran Wang
YCYaqi Cheng
Yaqi Cheng
WOWeijie Ouyang
Weijie Ouyang
XSXuan Sang
Xuan Sang
ZWZhichong Wang
Zhichong Wang
Age-related macular degeneration (AMD) is a blinding disease caused by multiple factors and is the primary cause of vision loss in the elderly. The morbidity of AMD increases every year. Currently, there is no effective treatment option for AMD. Intravitreal injection of antivascular endothelial growth factor (anti-VEGF) is currently the most widely used therapy, but it only aims at neovascularization, which is an intermediate pathological phenomenon of wet AMD, not at the etiological treatment. Anti-VEGF therapy can only temporarily delay the degeneration process of wet AMD, and AMD is easy to relapse after drug withdrawal. Therefore, it is urgent to deepen our understanding of the pathophysiological processes underlying AMD and to identify integrated or new strategies for AMD prevention and treatment. Recent studies have found that autophagy dysfunction in retinal pigment epithelial (RPE) cells, cellular senescence, and abnormal immune-inflammatory responses play key roles in the pathogenesis of AMD. For many age-related diseases, the main focus is currently the clearing of senescent cells (SNCs) as an antiaging treatment, thereby delaying diseases. However, in AMD, there is no relevant antiaging application. This review will discuss the pathogenesis of AMD and how interactions among RPE autophagy dysfunction, cellular senescence, and abnormal immune-inflammatory responses are involved in AMD, and it will summarize the three antiaging strategies that have been developed, with the aim of providing important information for the integrated prevention and treatment of AMD and laying the ground work for the application of antiaging strategies in AMD treatment.

28 July 2024 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
DYDan Yan
Dan Yan
CHCaihong Huang
Caihong Huang
WOWeijie Ouyang
Weijie Ouyang
JHJiaoyue Hu
Jiaoyue Hu
ZLZuguo Liu
Zuguo Liu

5 June 2026 in Molecular Biomedicine
Verified
Journal Article
Open access
PDF file
DYDan Yan
Dan Yan
JHJiaoyue Hu
Jiaoyue Hu
ZLZuguo Liu
Zuguo Liu
WOWeijie Ouyang
Weijie Ouyang
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway represents a cornerstone of innate immunity, functioning as the primary cytosolic DNA sensor in mammalian cells. Upon detecting pathogenic DNA or mislocalized self-DNA (such as leaked mitochondrial or micronuclear DNA), cGAS synthesizes the second messenger cGAMP, which subsequently activates endoplasmic reticulum-resident STING. This activation triggers an intricate signaling cascade involving liquid–liquid phase separation, dynamic organelle trafficking, and robust interferon and pro-inflammatory cytokine production, thereby bridging microbial defense, antitumor immunity, and cellular homeostasis. Despite these structural and functional insights, the pathway's context-dependent duality, dictating whether it activates protective acute immunity or drives pathological chronic inflammation, immunosuppression, and metabolic dysregulation, remains a critical, unresolved clinical challenge. This review systematically integrates recent breakthroughs across structural biology, nanotechnology, and clinical research to dissect the spatiotemporal dynamic regulation and non-canonical functions of the cGAS-STING axis. We comprehensively examine its cell-type-specific mechanisms and metabolic-immune crosstalk within the microenvironments of neurodegenerative diseases, oncology, and autoimmune disorders. Furthermore, we highlight emerging translational innovations, emphasizing the rational design of small molecule inhibitors, advanced nanocarrier delivery systems, and combination immunotherapies. By redefining the conventional understanding of cytosolic DNA sensing, this synthesis establishes a comprehensive roadmap for precision immunomodulation. Ultimately, it provides a crucial framework for developing next-generation, microenvironment-adaptive therapeutics that leverage spatiotemporal dynamics to treat cGAS-STING-related pathologies.

17 March 2026 in Experimental Eye Research
Verified
Journal Article
Closed access
DYDan Yan
Dan Yan
WOWeijie Ouyang
Weijie Ouyang
KLKuanshu Li
Kuanshu Li
XSXuguang Sun
Xuguang Sun